Global Placental Growth Factors Market to Witness Significant Growth: Projected to Reach USD 64.6 Million by 2033

Placental Growth Factors Market
Placental Growth Factors Market

The global placental growth factors market is poised for remarkable growth, with projections indicating a surge from USD 34.9 million in 2023 to an impressive USD 64.6 million by 2033. This robust growth trajectory reflects a steady compound annual growth rate (CAGR) of 6.3% during the forecast period.

Placental growth factors (PGFs) play a crucial role in ensuring the health and development of a pregnancy. These naturally occurring proteins, including vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), are essential for proper placental function and fetal development. As maternal health gains prominence globally, the demand for reliable diagnostic and therapeutic solutions to address complications such as pre-eclampsia and other placental-related disorders has surged.

Market Dynamics Driving Growth:

The market’s upward trend is fueled by:

  1. Advances in Medical Research: Breakthroughs in understanding placental biology and the role of growth factors in pregnancy outcomes are driving innovation in diagnostics and treatments.
  2. Rising Prevalence of Pregnancy Complications: The increasing incidence of conditions such as pre-eclampsia underscores the need for early detection and targeted intervention, boosting demand for PGF-based solutions.
  3. Government and Institutional Support: Initiatives promoting maternal and child health worldwide are fostering the adoption of advanced healthcare technologies.

Key Market Applications:

The placental growth factors market is a cornerstone in the assessment, diagnosis, and treatment of placental disorders. Healthcare providers leverage these biomarkers for early detection of complications, enabling timely medical intervention and improved maternal-fetal outcomes.

Future Outlook:

As awareness about maternal health grows, stakeholders in the healthcare sector are expected to increase investments in research and development of PGF-based products. This will not only enhance the quality of pregnancy care but also contribute to reducing maternal and neonatal morbidity rates globally.

Key Takeaways from the Placental Growth Factors Market:

  • The placental growth factors industry in the United States is predicted to reach USD 24.1 million by 2033, increasing at a 6.0% CAGR.
  • The placental growth factors industry in the United Kingdom is estimated to reach a market value of USD 2.8 million, expanding at a CAGR of 5.7% by 2033.
  • During the forecast period, the placental growth factors industry in China is expected to reach a market value of USD 5.6 million, securing a 7.0% CAGR.
  • The placental growth factors industry in Japan is predicted to reach USD 2.4 million by 2033, increasing at a 5.2% CAGR.
  • South Korea’s placental growth factors industry is predicted to achieve a market value of USD 1.0 million, rising at a 6.7% CAGR during the forecast period.
  • With value share of 57.0%, ophthalmology segment dominated the placental growth factors industry in 2022.
  • With value share of 51.2%, the pharmaceutical and biotechnology companies dominated the placental growth factors industry in 2022.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

How Does the Competition Look in the Placental Growth Factors Market?

The placental growth factors sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry Clearside BioMedical, Inc., Formycon AG, Alteogen Inc., Chengdu Kanghong Pharmaceuticals Group Co Ltd, ThromboGenics NV., Luye Pharma Group Ltd, Celltrion Inc, Alvotech SA, Amgen Inc, Cinnagen Co, Regeneron Pharmaceuticals Inc, and GlycoNex Inc.

The main corporations are investing extensively in research and development initiatives in order to develop inventive and creative products with improved reliability, efficacy, and cost. In order to meet changing consumer expectations, they are also concentrating on growing their product line and bolstering their distribution strategies.

Industry-wide, tactical alliances and partnerships with other businesses are more frequent, enabling parties to capitalize on one another’s advantages and increase their market power.

Leading companies employ mergers and consolidation to expand into new markets and improve their market share. In emerging markets, particularly in China and India, the sector is rapidly growing.

To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.

Key Developments in the Placental Growth Factors Market:

In March 2023, The suprachoroidal space (SCS®) is being revolutionised by Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical firm. Its results for the fourth quarter and year ending December 31, 2022, were released along with a corporate update.

Segmentation Analysis of the Placental Growth Factors Market

By Therapy Areas:

  • Ophthalmology
  • Metabolic Disorder
  • Oncology
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMO and CDMO

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these